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**SUPPORTING INFORMATION**

**Figure S1** SDS-PAGE analysis and Western blot of the N protein, the RBD of the S protein, and the binding curve of the RBD-mFc to human ACE2.

**Table S1** Demography and clinical classification of COVID-19 patients
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